Latest Fundraising News

A wild week for small-cap tech, led by a price-query rocket in DTI and a heavy sell-off in Qoria despite strong recurring revenue growth. Cash receipts, contract wins and capital raises did most of the talking, while a few gap moves showed how fast early gains can vanish.

A control fight and a big private equity payout topped this week’s finance moves, while several small-cap lenders and fund managers slid hard. Platform operators kept printing inflows, but investors stayed quick to punish anything that looked uncertain.

A takeover offer lit up small caps, while one high-growth software name slid hard despite strong sector news. Resources dominated the winners list, but investors still punished dilution and discounted fundraisings.

Jindalee Lithium Limited reported a cash outflow for the December 2025 quarter but maintains a solid cash position of A$6.5 million, with an estimated funding runway of 1.67 quarters. The company remains confident in securing additional financing to support its pre-development activities.

Auravelle Metals has reported significant high-grade gold intersections at its Sheoak Prospect in South Australia, extending the gold trend beyond 600 metres and identifying new targets at Sheoak East. Meanwhile, early drilling at its Crown Gold Project in Western Australia confirms extensive gold anomalism, supported by a successful $2.5 million capital raise to fund ongoing exploration.

Ballard Mining has raised $61 million through a well-supported placement to fund an aggressive drilling program and early development works at its Mt Ida Gold Project, positioning the company for a Final Investment Decision.

Golden Globe Resources has successfully completed an oversubscribed $8.5 million IPO and immediately commenced a significant drilling program at its flagship Dooloo Creek project in Queensland. The company is advancing exploration with a new geological model targeting high-grade gold and copper mineralisation.

Ryzon Materials will exit the ASX as it pursues a US exchange listing and prepares a fresh capital raise. The company remains focused on advancing its Nachu Graphite Project despite the transition.

A few stocks did the heavy lifting this week, with one biotech exploding higher and a gas name collapsing on the other side of the ledger. Big moves came from capital raises, regulator decisions, and drill results that investors treated as near-term value, not distant promises.

Navigator Global Investments reported steady ownership-adjusted assets under management of USD29 billion for the December 2025 quarter, buoyed by strong hedge fund performance and resilient private markets growth despite the Bardin Hill sale.

Zelira Therapeutics has raised nearly US$33 million from ThirdGate Capital to advance its HOPE® 1 drug targeting autism-related Phelan-McDermid Syndrome through FDA clinical trials. This funding milestone sets the stage for pivotal regulatory progress in the US.

Jayride Group Limited reports a reduced quarterly loss and secures fresh capital, yet faces ongoing uncertainty over its ability to continue as a going concern during its ASX reinstatement process.